Clinical trial

The Role of Amylin and Glucagon in T1DM

NCT00206258

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-07-01

PhasePHASE3

Study timeline

Study start (unknown)2002-07-01Date precision: month

Registry last updated2016-07-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

Pramlintide and glucagonDRUG

Sponsors & collaborators

Baylor College of Medicinelead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00206258 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.